Your browser doesn't support javascript.
loading
Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control.
Liu, Jing; Zhang, Huiqing; Kong, Jianing; Liu, Shiyi; Chen, Liping; Jiang, Yanming; Wang, Jie; Zhang, Binbin; Ye, Xiaoping; Gong, Ling; Zhou, Xiang; Chen, Gongying; Li, Jie; Pan, Xiaoben; Zhang, Haifeng; Shi, Junping.
Afiliação
  • Liu J; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Zhang H; Institute of Hepatology and Metabolic Diseases, School of Clinical Medicine, Hangzhou Normal University, Hangzhou, China.
  • Kong J; Institute of Hepatology and Metabolic Diseases, School of Clinical Medicine, Hangzhou Normal University, Hangzhou, China.
  • Liu S; Institute of Hepatology and Metabolic Diseases, School of Clinical Medicine, Hangzhou Normal University, Hangzhou, China.
  • Chen L; Institute of Hepatology and Metabolic Diseases, School of Clinical Medicine, Hangzhou Normal University, Hangzhou, China.
  • Jiang Y; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Wang J; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Zhang B; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Ye X; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Gong L; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Zhou X; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Chen G; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Li J; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Pan X; Department of Infectious Disease, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
  • Zhang H; Department of Infectious and Hepatology Diseases, The Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China.
  • Shi J; Department of Disease Biology, Global Health Drug Discovery Institute, Beijing, China.
J Med Virol ; 95(10): e29173, 2023 10.
Article em En | MEDLINE | ID: mdl-37822119
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article